Chemical structure of CAS 136572-09-3

Camptosar

CAS No.136572-09-3
MDL No.N/A
MFC33H45ClN4O9
MW677.20
InChI KeyKLEAIHJJLUAXIQ-JDRGBKBRSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Irinotecan hydrochloride hydrate is the trihydrate form of irinotecan hydrochloride. Onivyde is used in combination with fluorouracil and leucovorin for the treatment of metastatic pancreatic adenocarcinoma following gemcitabine-based therapy. It is hydrolyzed to its active metabolite, SN-38, which is ~1000 times more active. It functions as a DNA topoisomerase inhibitor, antineoplastic agent, apoptosis inducer, and prodrug. It contains irinotecan hydrochloride (anhydrous).

CAS No.136572-09-3
Product NameCamptosar
Heavy Atom Count47Rotatable Bond Count4
Atom Stereo Count1Bond Stereo Count0
HBA9HBD1
TPSA208.700 ŲCharge0
Exact Mass676.28751Complexity1699.84
pKa11.433XLogP2.039